Published May 2, 2019
University at Buffalo School of Pharmacy and Pharmaceutical Sciences Clinical Research Program students presented defenses for their theses on May 1.
The third- and fourth-year students prepared their defenses in the style of the 3-minute thesis, which was founded by the University of Queensland, Australia.
The Clinical Research Program (CRP) is an opportunity for third and fourth year PharmD students to elevate themselves for placement in fellowships and residencies via individualized research programs focused on excellent original clinical and translational research. The CRP has a proven track record of providing students robust didactic and experiential clinical research activities which prepares them to compete for competitive post graduate training positions.
|Emily Thurnherr||Dr. Calvin Meaney||Piperacillin/Tazobactam: More Nephrotoxic in Pediatric Patients than First Realized?|
|Hubert Chua||Dr. Brian Tsuji||Combining the Current Generation of Antibiotics with Zidovudine: Assessing it’s utility as Salvage Therapy|
|John Trendowski||Dr. Calvin Meaney||Erythropoietin Stimulating Agent Dynamics in Kidney in Transplant Recipients: A Prospective Title|
|Ebne Rafi||Dr. Scott Monte||Enhanced Recovery After Bariatric Surgery: A Retrospective review on Opioid Free Discharge|
|Elaine Shao||Dr. Scott Monte||Pharmacy Students’ Confidence and Ability Regarding De-Prescribing: A Cross Sectional Survey|
|Kory Zelen||Dr. Fran Gengo||The Impact of Abrupt Discontinuation of Chronic Aspirin on Stroke/TIA Events|
|Robert Parambi||Dr. Murali Ramanathan||Serum Neurofilaments and Cholesterol to Predict New Lesions and Brain Matter Atrophy in Multiple Sclerosis|
|Henry Wilson||Dr. Qing Ma||Bictegravir in the Elderly Living with HIV: Impact of Polypharmacy and Multi-Morbidity|
|Kate Zarudna||Dr. Calvin Meaney||Optimizing Erythropoiesis-Stimulating Agent Dosing: Achieving Target Hemoglobin Safely and Efficiently|